HOME >> MEDICINE >> NEWS
Concerta approved for ADHD in first European market

Medication offers relief from 'home to homework'

25 FEBRUARY 2002 London, UK -- A new, once-daily treatment for attention deficit hyperactivity disorder (ADHD), Concerta XL (methylphenidate HCl), has been approved in the United Kingdom, the first European Union country to license the product. Other regulatory reviews of the Janssen-Cilag medication are planned in the remainder of the European Union, and are in process in Latin America and the Asia-Pacific region.

It is estimated that ADHD affects 3-10 percent of school-age children. ADHD is characterised by a persistent inability to concentrate and pay attention, as well as by chronic hyperactivity and uncontrolled impulsiveness. The long-term results may include dysfunctional relationships with family and peers, poor academic achievement, and difficulty in obtaining and keeping gainful employment later in life. Medication is often part of a comprehensive management programme, including social, family and educational interventions.

"ADHD can cause serious disruptions in children's home and school lives, preventing their ability to perform well academically, be accepted by their peers and to integrate into their families," says Dr. Peter Hoare, an expert in ADHD at the Royal Hospital for Sick Children in Edinburgh, Scotland. "ADHD requires proper diagnosis and consistent, ongoing intervention. An effective, once-daily medication can increase initial acceptance of medical treatment and improve longer-term compliance."

Research has shown that Concerta can effectively control ADHD symptoms for 12 hours in adolescents and children as young as age six. This eliminates the need to take medication for the condition during school or extracurricular activities -- a routine that can be difficult to follow and have a negative impact on children's self-esteem. Concerta offers the most sustained relief of any form of methyphenidate -- the active ingredient in Concerta and the
'"/>

Contact: Carrie Monaghan
carrie.monaghan@ketchum.com
44-20-7611-3613
Ketchum
25-Feb-2002


Page: 1 2

Related medicine news :

1. Initiative yields effective methods for anthrax detection; RAMP and MIDI, Inc., methods approved
2. FDA-approved drugs shown to lower Alzheimer diseaserelated protein levels in mice
3. Newly approved psoriasis drug invented and tested at Univ. of Michigan
4. Xeloda approved for breast cancer treatment in Europe
5. First medicinal cannabis studies approved by research center
6. One of first bone marrow transplants for juvenile rheumatoid arthritis in the United States is approved for Oregon girl
7. Researchers search for first sign of congestive heart failure
8. Stanford patient is first to test new treatment for peripheral arterial disease
9. ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
10. Envisat enables first global check of regional methane emissions
11. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: